RT Journal Article
SR Electronic
T1 Underestimation of SARS-CoV-2 in wastewater due to single or double mutations in the N1 qPCR probe binding region
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.03.24302274
DO 10.1101/2024.02.03.24302274
A1 Sun, Jianxian
A1 Yang, Minqing Ivy
A1 Peng, Jiaxi
A1 Khan, Ismail
A1 Lopez, Jhoselyn Jaramillo
A1 Chan, Ronny
A1 Edwards, Elizabeth
A1 Peng, Hui
YR 2024
UL http://medrxiv.org/content/early/2024/02/04/2024.02.03.24302274.abstract
AB Wastewater surveillance using RT-qPCR has now been widely adopted to track circulating levels of SARS-CoV-2 virus in many sewer sheds. The CDC qPCR assays targeting two regions (N1 and N2) within the N gene are commonly used, but a discrepancy between the two biomarkers has been noticed by many groups using this method since late 2021. The reason is presumed to be due to mutations in regions targeted by the qPCR probe. In this study, we systematically investigated and unequivocally confirmed that the underlying reason for this discrepancy was mutations in the N1 probe target, and that a single mutation could cause a significant drop in signal. We first confirmed the proportion of related mutations in wastewater samples (Jan 2021-Dec 2022) using nested PCR and LC-MS. Based on relative proportion of N1 alleles, we separated the wastewater data into four time periods corresponding to different variant waves: Period I (Alpha and Delta waves with 0 mutation), Period II (BA.1/BA.2 wave with a single mutation found in all Omicron strains), Period III (BA. 5.2* wave with two mutations), and Period IV (BQ.1* wave with two mutations). Significantly lower N1 copies relative to N2 copies in samples from Periods II-IV compared to those from Period I was observed in wastewater. To further pinpoint the extent to which each mutation impacted N1 quantification, we compared the qPCR response among different synthetic oligomers with corresponding mutations. This study highlighted the impact of even just one or two mutations on qPCR-based wastewater surveillance of SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Ontario Wastewater Surveillance Initiative, and the Natural Sciences and Engineering Research Council (NSERC) Alliance Grant (ALLRP 576140). The authors acknowledge the support of instrumentation grants from the Canada Foundation for Innovation and the Ontario Research Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors